Question 1

Who are the top researchers at HRA Pharma (France)?

Accepted Answer

Ranked on the quality score, Tracy James and Erin Gainer lead among researchers whose main affiliation is HRA Pharma (France).

Question 2

What are the most cited papers from HRA Pharma (France)?

Accepted Answer

The most cited paper from HRA Pharma (France) is "Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis" (Anna F. Glasier, Sharon Tracey Cameron, Paul M Fine et al., 2010), with 530 citations. Next come "Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study" (173) and "Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture" (171).

Question 3

Which research topics does HRA Pharma (France) publish most on?

Accepted Answer

By volume in 2022-now: Reproductive Health and Contraception, Pregnancy and Medication Impact, Food composition and properties and Pharmacovigilance and Adverse Drug Reactions.

Question 4

Which keywords describe research at HRA Pharma (France)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Family Planning, Reproductive Health, Contraception, Unintended Pregnancy, Fertility, Immunosuppressive Drugs, Metabolic Syndrome and Maternal Mortality.

Question 5

Which fields of science does HRA Pharma (France) work in?

Accepted Answer

In all years, 82% of research at HRA Pharma (France) is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (78%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (4%). It does 2.8× the world's share of Health Sciences.

Question 6

Is HRA Pharma (France)'s research output growing?

Accepted Answer

Output in 2022-2025 was 70% higher than in 2018-2021.